what's trending

5 most popular innovation stories in Houston this week

Top news from Houston's innovation ecosystem included the announcement of the 2022 Houston Innovation Awards finalists, two cohorts revealed, and more. Photo via Pexels

Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, the finalists for the 2022 Houston Innovation Awards, and more.


3 Houston innovators to know this week

This week's roundup of Houston innovators includes Craig Ceccanti of T-Minus Solutions, Katie Eick of Rockin' Pets, Rollin' Vets, and Blair Garrou of Mercury. Photos courtesy

In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from venture capital to software — recently making headlines in Houston innovation. Continue reading.

Finalists named ahead of 2022 Houston Innovation Awards Gala

Here's what Houston startups and innovators will be honored at the Houston Innovation Awards Gala on November 9. Graphic via Gow Media

The Houston Innovation Awards Gala is just a few weeks away — and now the city knows who all it will be celebrating on November 9.

Eight judges evaluated over 150 companies and individuals across 11 categories for the 2022 Houston Innovation Awards. The event is a collaboration between InnovationMap and Houston Exponential to showcase the best of technology and innovation in the Bayou City.

This year's judges included Carolyn Rodz, founder and CEO of Hello Alice; Wogbe Ofori, founder of Wrx Companies; Scott Gale, executive director of Halliburton Labs; Ashley Danna, senior manager of regional economic development of Greater Houston Partnership; Kelly McCormick, professor at the University of Houston; Paul Cherukuri, vice president of innovation at Rice University; Lawson Gow, CEO of Houston Exponential; and Natalie Harms, editor of InnovationMap.

All 43 of the finalists will be honored at the gala on November 9, and winners will be named in each category. Additionally, the event will honor the 2022 Trailblazer Award recipient, Blair Garrou of Mercury, who was announced earlier this month. Continue reading,

Early-stage startup accelerator names latest Houston cohort

The latest Houston cohort for gBETA has been announced. Photo courtesy of gBETA

The sixth Houston cohort for global startup accelerator and investor gener8tor's gBETA program is underway, and five Houston early-stage companies have joined the program.

The no-equity program, which is based out of the Downtown Launchpad, kicked off in September and lasts seven weeks. In that time, the startups are connected to a national network of mentors, customers, corporate partners, and investors.

“This gener8tor Houston cohort is among our strongest yet,” says Robert Pieroni, director of Economic Development at Central Houston Inc., in the news release. “We are excited about the caliber of entrepreneurs the Downtown Launchpad is attracting and the entrepreneurial ecosystem being created.” Continue reading.

6 startups join Houston sports tech program

These sports innovation companies have joined Pokatok. Photo via Getty Images

A Houston-based organization focused on advancing sports tech startups has named its latest cohort.

Pokatok Labs announced the addition of six companies to its portfolio as the program — focused on seed and series A startups across health tech, gaming, fan experience, and more — kicks off. Lasting nine weeks and held twice a year, Pokatok's inaugural cohort was announced in May. Participating companies receive access to a network of organizations, advisors, investors, and subject matter experts within sports tech.

"We are pumped to launch our second cohort of all-star companies. If it's possible, this collection of startups may be even more outstanding than the last group," says Lawson Gow, Pokatok's co-founder. "We are eager to immerse them into the Texas market and to otherwise support their growth in any way that we can." Continue reading.

Exclusive: Houston Exponential names new CEO to lead strategy at the evolving organization

Meet Natara Branch — the new CEO of HX. Photo courtesy of Natara Branch

There's a new leader at the helm of an organization dedicated to advancing Houston's innovation ecosystem.

Natara Branch has been named as CEO of Houston Exponential. She started the new role earlier this month and replaces Lawson Gow, who temporarily held the responsibility when his company, Gow Companies, acquired the entity and transitioned it from a nonprofit into a for-profit. While Gow Cos. remains the parent company of HX, the organization will be led independently by its own set of leadership and board, which is in the process of being formed.

In her new role, Branch is focused on establishing the strategy of the evolved organization as well as strengthening and establishing key partnerships within Houston and beyond. Continue reading,

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News